The effect of peripheral percutaneous transluminal angioplasty on quality of life in patients with intermittent claudication

European Journal of Vascular and Endovascular Surgery

Volumn 26, Issue 2, 2003, Pages 130-136

  Cassar, K ^a   Bachoo, P ^b   Brittenden, J ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

Angioplasty; Intermittent claudication; Quality of life

Indexed keywords

BIBLIOGRAPHIC DATABASE; CLINICAL TRIAL; COCHRANE LIBRARY; EMBASE; FOLLOW UP; HUMAN; INTERMITTENT CLAUDICATION; MEDLINE; META ANALYSIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PUBLICATION; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; TREATMENT OUTCOME;

EID: 0042167564     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejvs.2002.1929     Document Type: Article

References (49)

1. Ruckley CV. Claudication. Br Med J 1986; 292: 970-971.
2. Leng GC, Lee AJ, Fowkes FGR et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epid 1996; 25: 1172-1181.
3. Scmieder FA, Comerota AJ. Intermittent claudication: magnitude of the problem, patient evaluation, and therapeutic strategies. Am J Card 2001; 87: 3D-13D.
4. Bowlin SJ, Medalie JH, Flocke SA, Zyzanski SJ, Goldbourt U. Epidemiology of intermittent claudication in middle-aged men. Am J Epid 1994; 140: 418-430.
5. Murabito JM, Evans JC, Nieto K, Larson MG, Levy D, Wilson PW. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J 2002; 143: 961-965.
6. Dormandy J, Heeck L, Vig S. The natural history of claudication: risk to life and limb. Semin Vase Surg 1999; 12: 123-137.
7. Dormandy J, Murray GD. The fate of the claudicant. A prospective study of 1969 claudicants. Eur J Vase Surg 1991; 5: 131-133.
8. Whyman MR, Ruckley CV, Fowkes FGR. Angioplasty for mild intermittent claudication. Br J Surg 1991; 78: 643-645
9. Gutteridge B, Torrie P. Galland B. Trends in arterial reconstruction, angioplasty and amputation. Health Trends 1994; 26: 88-91.
10. Pell JP, Whyman MR, Fowkes FGR, Gillespie I, Ruckley CV. Trends in vascular surgery since the introduction of percutaneous transluminal angioplasty. Br J Surg 1994; 81: 832-835.
11. Baker SR, Tan KL, Lawrence-Brown MM, Goodman MA, Prendergast FJ. Trends in the practice of arterial surgery in Western Australia. Aust N Z J Surg 1995; 65: 166-172.
12. Arfvidsson B, Karlsson J, Dahllof AG, Lundholm K, Sullivan M. The impact of intermittent claudication on quality of life evaluated by the Sickness. Impact Profile technique. Eur J Clin Invest 1993; 23: 741-745.
13. Ponte E, Cattinelli S. Quality of life in a group of patients with intermittent claudication. Angiology 1996; 47: 247-251.
14. Khaira HS, Hanger R, Shearmab CF. Quality of life in patients with intermittent claudication. Eur J Vasc Endovasc Surg 1996; 11: 65-69.
15. Bosch JL, Hunink MGM. The relationship between descriptive and valuational quality-of-life measure in patients with intermittent claudication. Med Decis Making 1996; 16: 217-225.
16. Pell JP. Impact of intermittent claudication on quality of life. The Scottish Vascular Audit Group. Eur J Vasc Endovasc Surg 1995; 9: 469-472.
17. Hicken GJ, Lossing AG, Ameli FM. Assessment of generic health-related quality of life in patients with intermittent claudication. Eur J Vasc Endovasc Surg 2000; 20: 336-341
18. Fowkes FGR, Gillespie IN. Angioplasty (versus non surgical management) for intermittent claudication. The Cochrane Library, 2002.
19. Trans-Atlantic Inter-Society Consensus (TASC). B6 clinical trial issues in intermittent claudication. J Vasc Surg 1999; 30: s131-s133.
20. Bosch JL, van der Graaf Y, Hinink M. Health-related quality of life after angioplasty and stent placement in patients with iliac artery occlusive disease: results of a randomised controlled clinical trial. Circulation 1999; 99: 3155-3160.
21. Whyman MR, Fowkes FGR, Kerracher EMG et al. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. Eur J Vasc Endovasc Surg 1996; 12: 167-172.
22. Whyman MR, Fowkes FGR, Kerracher EMG et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomised controlled trial. J Vasc Surg 1997; 26: 551-557.
23. Chetter IC, Spark JI, Kent PJ, Berridge DC, Scott DJA, Kester RC. Percutaneous transluminal angioplasty for intermittent claudication: evidence on which to base the medicine. Eur J Vasc Endovasc Surg 1998; 16: 477-484.
24. Chetter IC, Spark JI, Scott DJ, Kester RC. Does angioplasty improve the quality of life for claudicants? A prospective study. Ann of Vasc Surg 1999; 13: 93-103.
25. Cook TA, O'Regan M, Galland RB. Quality of life following percutaneous transluminal angioplasty for claudication. Eur J Vasc Endovasc Surg 1996; 11: 191-194.
26. Cook TA, Galland RB. Quality of life changes after angioplasty for claudication: medium-term results affected by comorbid conditions. Cardiovasc Surg 1997; 5: 424-426.
27. Currie IC, Wilson YG, Baird RN, Lamont PM. Treatment of Intermittent claudication: The impact on quality of life. Eur J Vasc Endovasc Surg 1995; 10: 356-361.
28. Klevsgard R, Hallberg IR, Risberg B, Thomsen MB. The effects of successful intervention on quality of life in patients with varying degrees of lower-limb ischaemia. Eur J Vasc Endovasc Surg 2000; 19: 238-245.
29. Pell JP, Lee AJ. Impact of angioplasty and arterial reconstructive surgery on the quality of life of claudicants. The Scottish Vascular Audit Group. Scot Med J 1997; 42: 47-48.
30. Hunt SM, McEwen J, McKenna SP, Backett EM, Pope C. Subjective health of patients with peripheral vascular disease. Practitioner 1982; 226: 133-136.
31. The Euroqol Group. EuroQol: a new facility for the measurement of health related quality of life. Health Policy 1990; 16: 199-208.
32. Hertzer NR. The natural history of peripheral vascular disease: implications for its management. Circulation 1991; 83:I12-I19.
33. Coffman JD. Intermittent claudication - be conservative. N Engl J Med 1991; 325: 577-578.
34. Wolfe F, Kong SX, Watson DJ. Gastrointestinal symptoms and health related quality of life in patients with arthritis. J Rheumatol 2000; 27: 1373-1378.
35. Campbell NC, Thain J, Deans HG, Ritchie LD, Rawles JM, Squair JL. Secondary prevention clinics for coronary heart disease: randomised trial of effect on health. BMJ 1998; 316: 1434-1437.
36. Slevin ML, Plant H, Lynch D, Drinkwater J, Gregory WM. Who should measure quality of life, the doctor or the patient? Br J Cancer 1988; 57: 109-112.
37. Pearlman RA, Uhlmann RF. Quality of life in chronic diseases: Perceptions of elderly patients. J Gerontol 1988; 43: M25-M30.
38. Keith RA. Functional status and health status. Arch Phys Med Rehabil 1994; 75: 478-483.
39. Murphy TP. Medical outcomes studies in peripheral vascular disease. J Vasc Int Rad 1998; 9: 879489.
40. Brevetti G, Annecchini R, Bucur R. Intermittent claudication: pharmacoeconomic and quality-of-life aspects of treatment. Pharmacoeconomics 2002; 20: 169-181.
41. Barletta G, Perna S, Sabba C, Catalano A, O'Boyle C, Brevetti G. Quality of life in patients with intermittent claudication: relationship with laboratory exercise performance. Vasc Med 1996; 1: 3-7.
42. Beattie DK, Golledge J, Greenhalgh RM, Davies AH. Quality of life assessment in vascular disease: towards a consensus. Eur J Vasc Endovasc Surg 1997; 13: 9-13.
43. Guyatt G. A taxonomy of health status instruments. J Rheumatol 1995; 22: 1188-1190.
44. Hiatt WR, Hirsch AT, Regensteiner JG, Brass EP. Clinical trials for claudication: assessment of exercise performance, functional status, and clinical end points. Circulation 1995; 92: 614-621.
45. Morgan MBF, Crayford T, Murrin B, Fraser SCA. Developing the Vascular Quality of Life Questionnaire: a disease-specific quality of life measure for use in lower limb ischaemia. J Vasc Surg 2001; 33: 679-687.
46. Silvertro A, Bacchieri A, Bucur R et al. A new questionnaire for assessing the quality of life of patients with intermittent claudication. Minerva Cardioangiologica 2000; 48: 455-465.
47. Marquis P, Comte S, Lehert P. International validation of the CLAU-S quality of life questionnaire for use in patients with intermittent claudication. Pharmacoeconomics 2001; 19: 667-677.
48. Chong PFS, Garratt AM, Golledge J, Greenhalgh RM, Davies AH. The intermittent claudication questionnaire: A Patient-assessed condition-specific health outcome measure. J Vasc Surg 2002; 36: 764-771.
49. Dotter CT, Judkins MP. Transluminal treatment of arteriosclerotic obstruction: description of a new technique and a preliminary report of its application. Circulation 1964; 30: 654-670.